Back

Have we found the Holy Grail in Heart failure with reduced ejection fraction? - First experiences with sacubitril/valsartan among heart transplant candidates

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Clinical Cases Pharmacotherapy HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Balazs Muk

Gottsegen National Cardiovascular Center, Budapest (Hungary)

28 More presentations in this session

Presentation thumbnail
A rare case of atrial septal defect with mitral valve papillary fibroelastoma
Mr A. Filias (Patras, GR)
Abstract
Presentation thumbnail
Belated diagnosis of non-ischemic dilated cardiomyopathy in a patient with previous bypass surgery
Doctor M. Bazmpani (Thessaloniki, GR)
Abstract
Presentation thumbnail
Successful percutaneous transcatheter closure of a prosthetic mitral paravalvular leak causing heart failure
Professor T. Habon (Pecs, HU)
Abstract
Presentation thumbnail
Significant reduction of insulin dose after administration of sacubitril/valsartan in the patient with heart failure due to dilated cardiomyopathy, a case report.
Doctor M. Hegarova (Prague, CZ)
Abstract Slides
Presentation thumbnail
Reversible left bundle branch block after sacubitril/valsartan in patient with severe heart failure
Doctor P. Lin (Hsinchu, TW)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Clinical Cases

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources